Literature DB >> 3456273

Activity of epirubicin in pancreatic carcinoma.

H Hochster, M D Green, J L Speyer, J C Wernz, R H Blum, F M Muggia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3456273

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Phase II evaluation of esorubicin (4'deoxydoxorubicin) in pancreatic adenocarcinoma: a Southwest Oncology Group study.

Authors:  C B Vaughn; S E Salmon; T R Fleming
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

Review 2.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.